AusCann
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
35 Havelock St L 4, West Perth, Western ...Phone Number
+61 863050705Website
www.auscann.com.auRevenue
$8.4 MillionIndustry
About AusCann
AusCann Org Chart
Is AusCann your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at AusCann
Check out if AusCann is spiking on competitors!
Earning: See what the market has to say on AusCann recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once AusCann has new funding data
Product Launch: Get notified when AusCann launches new products
AusCann, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AusCann has recently received funding, and reach out quickly before it becomes old news!
Click to see if AusCann had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at AusCann
Find more new buyers
Compare Similar Companies to AusCann
Compare insights from companies similar to AusCann, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AusCann is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AusCann is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AusCann.
AusCann Tech Stack
A closer look at the technologies used by AusCann
Most Recent Scoops
AusCann News & Media
AusCann (ASX:AC8) appoints CannPal's (ASX:CP1) MD as CEO of combined company
AusCann Group (ASX:AC8) has appointed CannPal Animal Therapeutics' (CP1) Founder and Managing Director, Layton Mills, as CEO of the combined company.Nick Woolf appointed as AusCann CEO
Nick Woolf (pictured) has been appointed as the new CEO of medicinal cannabis company AusCann (ASX: AC8), bringing considerable experience in the pharmaceuticals space along with him.Canopy Growth Announces Sale of Stake in AusCann
The companies will continue to collaborate in the Australian market SMITHS FALLS, ON, Oct. 15, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth") has sold its 42,087,639 shares in Australian cannabis company AusCann Group Holdings (AusCann) via an off...OTC Markets Group Welcomes AusCann Group Holdings Ltd. to OTCQX
NEW YORK, Sept. 11, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced AusCann Group Holdings Ltd. (ASX: AC8; OTCQX: ACNNF), an Australian-based pharmaceutical company that aims to produce high...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding AusCann
AusCann is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally. AusCann focuses on transforming the way medical cannabis is supplied by making standardised dose-controlled cannabinoid-based pharmaceutical products and clinical evidenc... Read More
